Gene: ZMYM5
Official Full Name: zinc finger MYM-type containing 5provided by HGNC
Gene Summary: Predicted to enable zinc ion binding activity. Involved in negative regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33470 | ZMYM5 Knockout cell line (HeLa) | Human | ZMYM5 | 1:3~1:6 | Negative | Online Inquiry |
KO33471 | ZMYM5 Knockout cell line (HCT 116) | Human | ZMYM5 | 1:2~1:4 | Negative | Online Inquiry |
KO33472 | ZMYM5 Knockout cell line (HEK293) | Human | ZMYM5 | 1:3~1:6 | Negative | Online Inquiry |
KO33473 | ZMYM5 Knockout cell line (A549) | Human | ZMYM5 | 1:3~1:4 | Negative | Online Inquiry |
ZMYM5 Gene Knockout Cell Lines are precision-engineered cellular models designed to facilitate research on the ZMYM5 gene, which has been implicated in various biological processes and diseases, including cancer. These cell lines have undergone targeted gene editing using CRISPR/Cas9 technology to achieve complete knockout of the ZMYM5 gene, enabling researchers to investigate the gene’s function and its role in cellular pathways.
The primary function of the ZMYM5 gene knockout cell lines is to provide a reliable platform for studying the biological impact of ZMYM5 loss, including its potential involvement in tumorigenesis and cell signaling pathways. By losing the expression of ZMYM5, researchers can assess changes in cellular morphology, proliferation rates, and gene expression profiles, allowing for in-depth analyses of downstream effects in various experimental settings.
Scientifically, these knockout cell lines serve as crucial tools in molecular biology and cancer research, contributing to a deeper understanding of genetic mechanisms underlying diseases. In clinical settings, they can play a significant role in the development of targeted therapies and personalized medicine, as insights gained from ZMYM5 investigations may lead to novel treatment strategies for cancers associated with its dysregulation.
Compared to alternative cell lines, ZMYM5 Gene Knockout Cell Lines offer unique advantages, including precise gene editing that ensures the complete ablation of ZMYM5 activity, thus providing clearer and more definitive results. Additionally, a stable knockout ensures reproducibility and reliability in experimental outcomes, which is often a challenge with transient gene silencing methods.
This product presents significant value to researchers, clinicians, and pharmaceutical companies alike by enabling more robust experimental designs and increasing the potential for groundbreaking discoveries in gene function and disease mechanisms. The precision and reliability of our ZMYM5 Gene Knockout Cell Lines, combined with our team’s extensive expertise in molecular genetics and cell line development, exemplify our commitment to providing high-quality products that advance scientific discovery and improve therapeutic strategies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.